Related Experiment Video

Updated: Apr 17, 2026

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs
09:37

Dopamine Release at Individual Presynaptic Terminals Visualized with FFNs

Published on: August 31, 2009

25.4K

Huntington's disease is the best investment in neuroscience today

Roy Maimon1

  • 1Department of Biomedical Engineering, Tandon School of Engineering, New York University, New York City, NY, USA; Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA.

Trends in Molecular Medicine
|February 14, 2026
PubMed

Insights

Huntington's disease (HD), though rare, offers a unique neuroscience research opportunity. Its clear genetics and predictable progression make it the clearest path toward advancing brain repair strategies.

Area of Science:

  • Neuroscience
  • Genetics
  • Neurological Disorders

Background:

  • Huntington's disease (HD) is characterized as a rare, tragic, and intractable neurological disorder.
  • Despite its severity, HD presents unique advantages for scientific research.

Purpose of the Study:

  • To highlight Huntington's disease as a strategic entry point for advancing neuroscience.
  • To leverage HD's distinct characteristics for developing brain repair therapies.

Main Methods:

  • Analysis of genetic clarity in Huntington's disease.
  • Evaluation of the predictable disease course in HD patients.
  • Assessment of the global HD community's organizational structure.

Main Results:

  • Huntington's disease possesses exceptional genetic clarity.
  • The disease progression in HD is relatively predictable.
  • An organized global community exists for HD research and support.

Conclusions:

  • The unique attributes of Huntington's disease provide the clearest pathway for significant advancements in brain repair.
  • HD research can serve as a model for understanding and treating other complex neurological conditions.

Keywords:
CAG repeatsHTT geneHuntington’s diseasebrain repairneurodegenerationtranslational

More Related Videos

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons10:53

Real-time Imaging of Axonal Transport of Quantum Dot-labeled BDNF in Primary Neurons

Published on: September 15, 2014

15.9K
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

12.8K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
3
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
2